News
Thursday, November 22nd, 2012
AHA: November 15, 2012 Background and Purpose—Few studies have evaluated long-term costs after stroke onset, with almost no cost data for transient ischemic attack (TIA). We studied hospital costs during the 5 years after TIA or stroke in a population-based study. Methods—Patients from a United Kingdom population-based cohort study (Oxford Vascular Study) were recruited from […]
News
Thursday, November 22nd, 2012
AHA: November 15, 2012 Background and Purpose—Approximately 5% of strokes occur in adults aged 18 to 44 years. Substance abuse is a prevalent risk factor for stroke in young adults. We sought to identify trends in substance abuse detection among stroke patients. Methods—Using a population-based design, we sought to identify all patients aged 18 to […]
News
Thursday, November 22nd, 2012
AHA: November 15, 2012 Background and Purpose—Telestroke reduces acute stroke care disparities between urban stroke centers and rural hospitals. Current technologies used to conduct remote patient assessments have high start-up costs, yet they cannot consistently establish quality timely connections. Smartphones can be used for high-quality video teleconferencing. They are inexpensive and ubiquitous among health care […]
News
Thursday, November 22nd, 2012
Background: Soft drink intake has been associated with obesity and diabetes, but its relation with risk of cardiovascular disease (CVD) is limited. Objective: We examined the association between soft drink intake and risk of CVD in a Japanese population. Design: This was a prospective study in 39,786 Japanese men and women aged 40–59 y in which soft drink […]
Atrial Fibrillation
Tuesday, November 20th, 2012
The Lancet: 12/1/12 The world faces an epidemic of atrial fibrillation and atrial fibrillation-related stroke. An individual’s risk of atrial fibrillation-related stroke can be estimated with the CHADS2 or CHA2DS2VASc scores, and reduced by two-thirds with effective anticoagulation. Vitamin K antagonists, such as warfarin, are underused and often poorly managed. The direct thrombin inhibitor dabigatran etexilate […]
Atrial Fibrillation
Tuesday, November 20th, 2012
American Heart Association: 11/6/12 Atrial fibrillation (AF) is the most common sustained arrhythmia, and its prevalence in the population is increasing.1 Diastolic dysfunction shares many common risk factors with AF, including age, hypertension,2–5 obesity,6,7 and diabetes.8,9 Like AF, diastolic dysfunction increases with age,10 and patients given the diagnosis of diastolic dysfunction are more likely to have AF at the time.11 Diastolic dysfunction […]
News
Tuesday, November 20th, 2012
DUKE: 11/5/12 The study was conducted by the DCRI’s Benjamin A. Steinberg, MD (pictured); Sunghee Kim, PhD; Kenneth W. Mahaffey, MD; Laine Thomas, PhD; Jonathan P. Piccini, MD, MHS; Eric D. Peterson, MD, MPH, and colleagues from other institutions. Steinberg served as first author of the study, and Peterson served as senior author. The study was […]
Atrial Fibrillation
Tuesday, November 20th, 2012
Stopafib: 11/5/12 WASHINGTON, DC (November 5, 2012) — The Alliance for Aging Research (Alliance) and the AFib Optimal Treatment Task Force announced the results of an on-line survey of patients 65+ years old, exploring their experiences with the diagnosis and treatment of their atrial fibrillation (AFib). The objectives of the survey of more than 500 AFib […]
Atrial Fibrillation
Tuesday, November 20th, 2012
Wiley: 11/2/12 Although warfarin is superior to aspirin in reducing the risk of stroke in patients with atrial fibrillation, it can increase major bleeds. Hence physicians stratify patients according to stroke risk to ensure a net benefit. In this review, the CHA2DS2-VASc stratification scheme used in the latest European Society of Cardiology (2010/12) guidelines will be […]
Clinical Trials
Tuesday, November 20th, 2012
American Heart Association: November 13, 2012 Background and Purpose—The modified Rankin Scale (mRS) is the recommended functional outcome assessment in stroke trials. Utility of mRS may be limited by interobserver variability. prestroke function, described using mRS, is often used as trial entry criterion. We assessed the reliability and validity of prestroke mRS in acute stroke. Methods—We […]
